The role of vitronectin receptor (αv/β3) and tissue factor in the pathogenesis of transplant coronary vasculopathy

Journal of the American College of Cardiology

Volumn 39, Issue 5, 2002, Pages 804-810

  Yamani, Mohamad H ^a,b   Masri, Carolina S ^a,b   Ratliff, Norman B ^a   Bond, Meredith ^a   Starling, Randall C ^a,b   Tuzcu, E Murat ^a,b   McCarthy, Patrick M ^b   Young, James B ^a,b  

^a Learner Research Institute   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; PEROXIDASE; THROMBOPLASTIN; VITRONECTIN RECEPTOR;

ADULT; ARTICLE; AUTOMATION; COHORT ANALYSIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DONOR; FEMALE; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; WESTERN BLOTTING;

CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; RECEPTORS, VITRONECTIN; SEVERITY OF ILLNESS INDEX; THROMBOPLASTIN; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL; UP-REGULATION;

EID: 0037028916     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01823-X     Document Type: Article

References (29)

1. Mechanisms of immune-mediated myocyte injury
2. Ligand recognition by β3 integrins
3. The vitronectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23
4. Vitronectin and its receptor
5. Tissue factor in atherosclerosis
6. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque thrombogenecity
7. Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells
8. Role of integrin αvβ3 in vascular biology
9. Acute vascular (humoral) rejection in non-OKT3 treated cardiac transplants
10. Vascular rejection in cardiac transplantation: Histologic immunopathologic and ultrastructural features
11. A novel method based on computerized scoring of rejection for the prediction of coronary vasculopathy validated by intravascular ultrasound
12. Comparative study on age-related changes and atherosclerotic involvement of the coronary arteries of male and female subjects up to 40 years of age
13. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: Evidence from intravascular ultrasound
14. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays
15. Activation of integrin receptors is required for growth factor-induced smooth muscle cell dysfunction
16. The alpha v beta 3 integrin "vitronectin receptor"
17. Anchorage dependence, integrins, and apoptosis
18. Tissue factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts
19. Cultured human endothelial cells generate tissue factor in response to endotoxin
20. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the action of interleukin 1
21. Regulation of tissue factor gene expression in human monocytic and endothelial cells
22. Tissue factor induces migration of cultured aortic smooth muscle cells
23. In-situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy
24. Tissue factor and hemostasis
25. Cardiac allograft vasculopathy: Current concepts, recent developments, and future directions
26. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection
27. Myocardial fibrin deposits in first month after transplantation predict subsequent coronary artery disease and graft failure in cardiac allograft recipients
28. Vascular tissue plasminogen activator and the development of coronary artery disease in heart transplant recipients
29. Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular disease